The Economic Evaluation and Analysis (EEA) team assists countries to collect, evaluate and introduce economic evidence into health policy. Cognizant from the start of resource constraints in countries at whatever income level, prioritization with a focus on allocative and technical efficiency is a key work area. Addressing the resource allocation decisions that policymakers regularly face, the work area on value for money and prioritization also includes considerations of health system feasibility, costs and budget impact, and an assessment of the contribution of improved health to the economy. EEA also measures and evaluates the impact of health financing and other policies on universal health coverage, specifically on equity and on financial protection. All these are accomplished by leading, advocating, and developing methods, tools, and standards, by increasing country capacity, and by providing technical assistance to countries to produce and to use economic evidence.

If you have a query or feedback please contact

Mailing address

Economic Evaluation and Analysis (EEA)
Department of Health systems Governance and Financing (HGF)
World Health Organization
20 Avenue Appia
CH 1211 Geneva 27
Switzerland